دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Stop smoking and sleep well to reduce cardiovascular risk
Filippo Crea
doi : 10.1093/eurheartj/ehab731
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4097–4100
Cardiovascular clinical examination: the need for an evidence-based approach
Ganesan Karthikeyan
doi : 10.1093/eurheartj/ehab327
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4101–4102
Inspired by a Nobel prizewinning father
Mark Nicholls
doi : 10.1093/eurheartj/ehab200
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4103–4105
The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world
Dimitris Tousoulis, Evangelos Oikonomou, John Kanakakis
doi : 10.1093/eurheartj/ehab317
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4105–4106
Cardiology Update, Davos, 24–26 October 2021, Swiss Cardiology in the European Showcase
Ruth Amstein
doi : 10.1093/eurheartj/ehab394
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4106–4108
Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism
Maria Lucia Narducci, Carlo Patrono
doi : 10.1093/eurheartj/ehab590
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4109–4110
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
Kazuomi Kario, Akihiro Nomura, Noriko Harada, Ayako Okura, Kiyose Nakagawa, Tomoyuki Tanigawa, Eisuke Hida
doi : 10.1093/eurheartj/ehab559
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4111–4122
Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal trial investigated the efficacy of digital therapeutics in patients with hypertension not receiving antihypertensive medication.
Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
Luis M Ruilope, Pedro L Valenzuela, Alejandro Lucia
doi : 10.1093/eurheartj/ehab694
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4123–4125
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study
Myrthe M A Toorop, Qingui Chen, Vladimir Y I G Tichelaar, Suzanne C Cannegieter, Willem M Lijfering
doi : 10.1093/eurheartj/ehab421
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4126–4137
Persistence with direct oral anticoagulants (DOACs) has become a concern in non-valvular atrial fibrillation (NVAF) patients, but whether this affects prognosis is rarely studied. We investigated the persistence with oral anticoagulants (OACs) and its association with prognosis among a nationwide cohort of NVAF patients.
Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants
Peter Vibe Rasmussen, Elaine Hylek
doi : 10.1093/eurheartj/ehab524
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4138–4140
Smoking cessation, but not reduction, reduces cardiovascular disease incidence
Su-Min Jeong, Keun Hye Jeon, Dong Wook Shin, Kyungdo Han, Dahye Kim, Sang Hyun Park, Mi Hee Cho, Cheol Min Lee, Ki-Woong Nam, Seung Pyo Lee
doi : 10.1093/eurheartj/ehab578
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4141–4153
The aim of this study was to assess the association of smoking cessation and reduction with risk of cardiovascular disease (CVD).
Importance of smoking cessation for cardiovascular risk reduction
Amalie Lykkemark Møller, Charlotte Andersson
doi : 10.1093/eurheartj/ehab541
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4154–4156
Chronic venous insufficiency, cardiovascular disease, and mortality: a population study
Jürgen H Prochaska, Natalie Arnold, Andrea Falcke, Sabrina Kopp, Andreas Schulz, Gregor Buch, Sophie Moll, Marina Panova-Noeva, Claus Jünger, Lisa Eggebrecht, Norbert Pfeiffer, Manfred Beutel, Harald Binder, Stephan Grabbe, Karl J Lackner, Arina ten Cate-Hoek, Christine Espinola-Klein, Thomas Münzel, Philipp S Wild
doi : 10.1093/eurheartj/ehab495
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4157–4165
Evidence regarding the health burden of chronic venous insufficiency (CVI), its clinical determinants, and impact on outcome is scarce.
The legs are a pathway to the heart: connections between chronic venous insufficiency and cardiovascular disease
Naomi M Hamburg
doi : 10.1093/eurheartj/ehab589
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4166–4168
Insomnia symptoms and incident heart failure: a population-based cohort study
Asos Mahmood, Meredith Ray, Aram Dobalian, Kenneth D Ward, SangNam Ahn
doi : 10.1093/eurheartj/ehab500
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4169–4176
Heart failure (HF) is an ongoing epidemic and a serious clinical and public health issue. Currently, little is known about prospective associations between insomnia symptoms and HF incidence. We investigated the longitudinal associations between time-varying insomnia symptoms (difficulty initiating sleep, difficulty maintaining sleep, early-morning awakening, non-restorative sleep) and incident HF.
Insomnia, a new modifiable risk factor for heart failure?
Mathieu Berger, Geoffroy Solelhac, Frédéric Roche, Raphael Heinzer
doi : 10.1093/eurheartj/ehab570
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4177–4179
Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease
Ningjian Wang, Ying Sun, Haojie Zhang, Bin Wang, Chi Chen, Yuying Wang, Jie Chen, Xiao Tan, Jihui Zhang, Fangzhen Xia, Lu Qi, Yingli Lu
doi : 10.1093/eurheartj/ehab505
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4180–4188
The aim of this study was to test whether current and past night shift work was associated with incident atrial fibrillation (AF) and whether this association was modified by genetic vulnerability. Its associations with coronary heart disease (CHD), stroke, and heart failure (HF) were measured as a secondary aim.
Keep your rhythm during rotational night work shifts!
Dominik Linz, Michael Arzt, Mathias Baumert
doi : 10.1093/eurheartj/ehab623
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4189–4191
Air pollution and cardiovascular diseases in young adults
Yanguo Xin, Junli Li
doi : 10.1093/eurheartj/ehab613
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Page 4192
Potential effects of time-varying characteristics and discrepancies in covariates distribution upon interpreting the results from the association of air pollution and physical activity with cardiovascular disease among young adults
Seong Rae Kim, Seulggie Choi, Sang Min Park
doi : 10.1093/eurheartj/ehab615
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4193–4194
Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent
Longrong Bian, Zhi Fang, Hong Qian, Zhong Wu
doi : 10.1093/eurheartj/ehaa711
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Page 4195
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J Bax, Carina Blomström-Lundqvist, Giuseppe Boriani, Manuel Castella, Gheorghe-Andrei Dan, Polychronis E Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M Kalman, Mark La Meir, Deirdre A Lane, Jean-Pierre Lebeau, Maddalena Lettino, Gregory Y H Lip, Fausto J Pinto, G Neil Thomas, Marco Valgimigli, Isabelle C Van Gelder, Bart P Van Putte, Caroline L Watkins
doi : 10.1093/eurheartj/ehab648
European Heart Journal, Volume 42, Issue 40, 21 October 2021, Page 4194
